Free Trial
→ A simple options setup that cuts through the noise (From TradeWins) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Chemed Corporation stock logo
CHE
Chemed
$499.14
+0.2%		$521.28
$365.20
▼
$557.00
$6.51B0.51164,772 shs134,463 shs
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$231.07
+0.1%		$237.55
$171.18
▼
$248.84
$25.48B0.541.20 million shs775,449 shs
Labcorp Holdings Inc. stock logo
LH
Labcorp
$311.99
-0.7%		$320.21
$244.52
▼
$341.80
$25.48B0.87815,273 shs607,853 shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$612.05
+1.6%		$602.77
$373.00
▼
$677.90
$16.82B1.18262,840 shs159,763 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Chemed Corporation stock logo
CHE
Chemed
-0.03%-1.87%-3.66%+2.33%+14.80%
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
+0.14%-0.96%-1.96%+11.31%+27.77%
Labcorp Holdings Inc. stock logo
LH
Labcorp
-0.81%+1.11%-2.86%+12.71%+12.45%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
+1.55%+2.10%+4.39%+13.72%+15.26%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Chemed Corporation stock logo
CHE
Chemed
$499.14
+0.2%		$521.28
$365.20
▼
$557.00
$6.51B0.51164,772 shs134,463 shs
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$231.07
+0.1%		$237.55
$171.18
▼
$248.84
$25.48B0.541.20 million shs775,449 shs
Labcorp Holdings Inc. stock logo
LH
Labcorp
$311.99
-0.7%		$320.21
$244.52
▼
$341.80
$25.48B0.87815,273 shs607,853 shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$612.05
+1.6%		$602.77
$373.00
▼
$677.90
$16.82B1.18262,840 shs159,763 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Chemed Corporation stock logo
CHE
Chemed
-0.03%-1.87%-3.66%+2.33%+14.80%
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
+0.14%-0.96%-1.96%+11.31%+27.77%
Labcorp Holdings Inc. stock logo
LH
Labcorp
-0.81%+1.11%-2.86%+12.71%+12.45%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
+1.55%+2.10%+4.39%+13.72%+15.26%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Chemed Corporation stock logo
CHE
Chemed
2.29
Hold$554.6011.11% Upside
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
2.58
Moderate Buy$237.852.93% Upside
Labcorp Holdings Inc. stock logo
LH
Labcorp
2.75
Moderate Buy$337.738.25% Upside
Medpace Holdings, Inc. stock logo
MEDP
Medpace
2.23
Hold$607.73-0.71% Downside

Current Analyst Ratings Breakdown

Latest CHE, MEDP, DGX, and LH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/8/2026
Chemed Corporation stock logo
CHE
Chemed
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C) ➝ Hold (C+)
10/8/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeBuy (B-) ➝ Buy (B)
10/7/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Mizuho logo
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$665.00 ➝ $700.00
10/7/2026
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$250.00 ➝ $260.00
10/7/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$600.00 ➝ $625.00
10/6/2026
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeBuy (A-) ➝ Buy (A)
10/6/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeBuy (B) ➝ Buy (B+)
9/30/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageSell ➝ Neutral$405.00 ➝ $673.00
9/30/2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell ➝ Hold$405.00 ➝ $673.00
9/25/2026
Chemed Corporation stock logo
CHE
Chemed
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$650.00
9/25/2026
Chemed Corporation stock logo
CHE
Chemed
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$650.00
(Data available from 10/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Chemed Corporation stock logo
CHE
Chemed
$2.53B2.58$24.71 per share20.20$69.15 per share7.22
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$11.04B2.31$15.19 per share15.21$64.78 per share3.57
Labcorp Holdings Inc. stock logo
LH
Labcorp
$13.95B1.81$24.66 per share12.65$103.98 per share3.00
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$2.53B6.75$17.28 per share35.42$16.30 per share37.55
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Chemed Corporation stock logo
CHE
Chemed
$265.24M$19.9125.0719.832.0010.60%31.77%18.90%10/27/2026 (Estimated)
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$992M$9.4224.5319.302.099.18%16.01%7.27%10/22/2026 (Estimated)
Labcorp Holdings Inc. stock logo
LH
Labcorp
$876.50M$12.0925.8115.851.796.99%16.74%7.81%10/28/2026 (Estimated)
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$451.12M$17.0635.8831.932.6917.67%110.15%24.84%10/21/2026 (Confirmed)

Latest CHE, MEDP, DGX, and LH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/28/2026Q3 2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
$4.65N/AN/AN/A$3.76 billionN/A
10/27/2026Q3 2026
Chemed Corporation stock logo
CHE
Chemed
$6.39N/AN/AN/A$685.04 millionN/A
10/22/2026Q3 2026
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$2.87N/AN/AN/A$3.05 billionN/A
10/21/2026Q3 2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$4.44N/AN/AN/A$714.47 millionN/A
7/30/2026Q2 2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
$4.78$4.99+$0.21$3.64$3.71 billion$3.73 billion
7/28/2026Q2 2026
Chemed Corporation stock logo
CHE
Chemed
$5.60$6.06+$0.46$5.13$665.04 million$673.25 million
7/23/2026Q2 2026
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$2.82$3.12+$0.30$2.84$2.97 billion$3.04 billion
7/22/2026Q2 2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.98$4.25+$0.27$4.25$689.51 million$707.33 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Chemed Corporation stock logo
CHE
Chemed
$2.800.56%+10.76%14.06%16 Years
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$3.441.49%+7.34%36.52%14 Years
Labcorp Holdings Inc. stock logo
LH
Labcorp
$2.880.92%N/A23.82%N/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/AN/AN/AN/AN/A

Latest CHE, MEDP, DGX, and LH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/12/2026
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
quarterly$0.861.51%10/6/202610/6/202610/21/2026
8/6/2026
Chemed Corporation stock logo
CHE
Chemed
quarterly$0.700.53%8/17/20268/17/20269/3/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Chemed Corporation stock logo
CHE
Chemed
0.17
0.91
0.89
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
0.72
1.59
1.46
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.69
1.80
1.53
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/A
0.73
0.73

Institutional Ownership

CompanyInstitutional Ownership
Chemed Corporation stock logo
CHE
Chemed
95.85%
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
88.06%
Labcorp Holdings Inc. stock logo
LH
Labcorp
95.94%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
77.98%

Insider Ownership

CompanyInsider Ownership
Chemed Corporation stock logo
CHE
Chemed
3.33%
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
0.88%
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.84%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
20.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Chemed Corporation stock logo
CHE
Chemed
15,81113.07 million12.64 millionOptionable
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
57,000110.37 million109.40 millionOptionable
Labcorp Holdings Inc. stock logo
LH
Labcorp
71,00081.10 million80.42 millionOptionable
Medpace Holdings, Inc. stock logo
MEDP
Medpace
6,20027.91 million22.19 millionOptionable

Recent News About These Companies

Medpace Holdings (MEDP) Receives a Buy from RBC Capital
October 10 at 7:16 AM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/MEDP/pressreleases/5019705/medpace-holdings-medp-receives-a-buy-from-rbc-capital/
4,668 Shares in Medpace Holdings, Inc. $MEDP Purchased by Monument Capital Management
October 9 at 7:36 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-4668-shares-in-medpace-holdings-inc-medp-purchased-by-monument-capital-management-2026-10-09/
Medpace Holdings, Inc. $MEDP Shares Purchased by Artemis Investment Management LLP
October 8 at 1:19 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-medpace-holdings-inc-medp-shares-purchased-by-artemis-investment-management-llp-2026-10-08/
Medpace Holdings stock holds at USD 604.25 as analysts stay at Hold
October 8 at 3:12 AM  |  ad-hoc-news.deA
Medpace stock heads into October 21 results after a 2.84 percent fall
October 7 at 10:12 PM  |  ad-hoc-news.deA
Troendle sells Medpace stock. UBS sets a USD 673 target.
October 7 at 7:10 AM  |  ad-hoc-news.deA
Congress Asset Management Co. Raises Holdings in Medpace Holdings, Inc. $MEDP
October 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-congress-asset-management-co-raises-holdings-in-medpace-holdings-inc-medp-2026-10-06/
Medpace (MEDP) Stock Declines While Market Improves: Some Information for Investors
October 6, 2026  |  zacks.comhttps://www.zacks.com/stock/news/3001416/medpace-medp-stock-declines-while-market-improves-some-information-for-investors?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_6v3-3001416
UBS sets USD 673 target for Medpace stock
October 6, 2026  |  ad-hoc-news.deA
Medpace Holdings, Inc. $MEDP Stock Holdings Decreased by Argent Capital Management LLC
October 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-medpace-holdings-inc-medp-stock-holdings-decreased-by-argent-capital-management-llc-2026-10-05/
UBS upgrades Medpace Holdings to neutral from sell
October 3, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/ubs-upgrades-medpace-holdings-to-neutral-from-sell/ar-AA2dro9C
Medpace (NASDAQ:MEDP) Stock: Insider August Troendle Sells 21,966 Shares
October 3, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31082385
Medpace CEO Troendle sells $1.59 million of stock
October 2, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31078406
Insider Selling: Medpace (NASDAQ:MEDP) CEO Sells $13,739,074.02 in Stock
October 2, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-medp-insider-buying-and-selling-2026-10-02/
Medpace Holdings Insider Sold Shares Worth $30,320,929, According to a Recent SEC Filing
October 1, 2026  |  marketscreener.comM
Medpace Holdings Insider Sold Shares Worth $30,320,929, According to a Recent SEC Filing
October 1, 2026  |  marketscreener.comM
Medpace (NASDAQ:MEDP) CEO Sells $13,739,074.02 in Stock
October 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-medpace-nasdaq-medp-ceo-sells-1373907402-in-stock-2026-10-01/
Medpace (NASDAQ:MEDP) Stock: Insider August Troendle Sells 26,701 Shares
October 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-medpace-nasdaq-medp-stock-insider-august-troendle-sells-26701-shares-2026-10-01/
Medpace (NASDAQ:MEDP) Raised to Hold at UBS Group
October 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-medpace-nasdaq-medp-raised-to-hold-at-ubs-group-2026-10-01/
Medpace (NASDAQ:MEDP) Stock: Insider August Troendle Sells 154 Shares
October 1, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31073391
Medpace (NASDAQ:MEDP) Stock: Insider August Troendle Sells 2,410 Shares
October 1, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31073031

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Computer monitor with a red plunging chart arrow on a desk, symbolizing software stocks selloff amid AI fears.
MarketBeat's Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
By Thomas Hughes | September 15, 2026
Television displaying the Netflix logo in a dark living room with a coffee table, popcorn bowl, and remote.
Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?
By Sam Quirke | September 30, 2026
Six Flags logo displayed over a roller coaster and lake at sunset in an amusement park setting.
Six Flags Launches FlexPay—Is There Any FUN Left in the Stock?
By Chris Markoch | September 28, 2026
LNG tanker with rounded storage domes docked at a coastal terminal with large storage tanks and pipelines.
Running on Empty: 3 Energy Plays for Europe's Deep Freeze
By Jeffrey Neal Johnson | September 15, 2026
Glass-walled office building lobby at sunset with a city skyline reflected in the exterior facade.
Data Centers Got the AI Hype—But Office REITs May Get the Rent Hikes
By Chris Markoch | September 27, 2026
Chemed stock logo

Chemed NYSE:CHE

$499.14 +0.89 (+0.18%)
Closing price 10/9/2026 03:59 PM Eastern
Extended Trading
$492.57 -6.57 (-1.32%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Quest Diagnostics stock logo

Quest Diagnostics NYSE:DGX

$231.07 +0.26 (+0.11%)
Closing price 10/9/2026 03:59 PM Eastern
Extended Trading
$231.50 +0.43 (+0.18%)
As of 10/9/2026 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Labcorp stock logo

Labcorp NYSE:LH

$311.99 -2.21 (-0.70%)
Closing price 10/9/2026 03:59 PM Eastern
Extended Trading
$315.36 +3.37 (+1.08%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Medpace stock logo

Medpace NASDAQ:MEDP

$612.05 +9.35 (+1.55%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$611.57 -0.48 (-0.08%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas